KCNJ8 and migraine disorder: The targeted blocking of Kir6.1 or SUR2B KATP channel subunits in large cerebral and meningeal arteries may be a future anti-migraine strategy as they might not have any CNS or cardiac or endocrine effect (insulin release) [53,64].